Wu et al. [89] indicated that β2M was increased in COPD patients and was correlated with lower pulmonary diffusing capacity values, increased alveolar wall/septal thickening (fibrosis changes), and higher expressions of TGF-β1, Smad4, and a-SMA. Here, TGFB1 is linked to chronic obstructive pulmonary disease.